148 related articles for article (PubMed ID: 34436020)
1. Recommending Unfunded Innovative Cancer Therapies: Ethical vs. Clinical Perspectives among Oncologists on a Public Healthcare System-A Mixed-Methods Study.
Bashkin O; Dopelt K; Asna N; Davidovitch N
Curr Oncol; 2021 Aug; 28(4):2902-2913. PubMed ID: 34436020
[TBL] [Abstract][Full Text] [Related]
2. Patients' and oncologists' perceptions towards the discussion on high-cost innovative cancer therapies: findings from a qualitative study.
Bashkin O; Dopelt K; Asna N
BMJ Open; 2022 Sep; 12(9):e062104. PubMed ID: 36167390
[TBL] [Abstract][Full Text] [Related]
3. Current Attitudes toward Unfunded Cancer Therapies among Canadian Medical Oncologists.
Wong SK; Gondara L; Gill S
Curr Oncol; 2021 Nov; 28(6):4748-4755. PubMed ID: 34898584
[TBL] [Abstract][Full Text] [Related]
4. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
5. Variation and consternation: access to unfunded cancer drugs in Canada.
Berry SR; Evans WK; Strevel EL; Bell CM
J Oncol Pract; 2012 Jan; 8(1):35-9. PubMed ID: 22548009
[TBL] [Abstract][Full Text] [Related]
6. Discussing and prescribing expensive unfunded anticancer drugs in Australia.
Karikios DJ; Mileshkin L; Martin A; Ferraro D; Stockler MR
ESMO Open; 2017; 2(2):e000170. PubMed ID: 28761744
[TBL] [Abstract][Full Text] [Related]
7. Oncologists' reflections on patient rights and access to compassionate use drugs: A qualitative interview study from an academic cancer center.
Stout J; Smith C; Buckner J; Adjei AA; Wentworth M; Tilburt JC; Master Z
PLoS One; 2021; 16(12):e0261478. PubMed ID: 34919568
[TBL] [Abstract][Full Text] [Related]
8. Oncologists' Perceptions of Drug Affordability Using NCCN Evidence Blocks: Results from a National Survey.
Shah-Manek B; Wong W; Ravelo A; DiBonaventura M
J Manag Care Spec Pharm; 2018 Jun; 24(6):565-571. PubMed ID: 29451078
[TBL] [Abstract][Full Text] [Related]
9. Physician-patient communication of costs and financial burden of cancer and its treatment: a systematic review of clinical guidelines.
Agarwal A; Livingstone A; Karikios DJ; Stockler MR; Beale PJ; Morton RL
BMC Cancer; 2021 Sep; 21(1):1036. PubMed ID: 34530765
[TBL] [Abstract][Full Text] [Related]
10. Less than ideal: how oncologists practice with limited drug access.
Chan KK; Wong B; Siu LL; Straus SE; Chang J; Berry SR
J Oncol Pract; 2012 May; 8(3):190-5. PubMed ID: 22942815
[TBL] [Abstract][Full Text] [Related]
11. Overcoming obstacles in accessing unfunded oral chemotherapy: physician experience and challenges.
Han D; Trinkaus M; Hogeveen S; Mamdani M; Berry SR; Jang RW; Hoch JS; Simmons C
J Oncol Pract; 2013 Jul; 9(4):188-93. PubMed ID: 23942919
[TBL] [Abstract][Full Text] [Related]
12. Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs.
Berry SR; Bell CM; Ubel PA; Evans WK; Nadler E; Strevel EL; Neumann PJ
J Clin Oncol; 2010 Sep; 28(27):4149-53. PubMed ID: 20697077
[TBL] [Abstract][Full Text] [Related]
13. Mind the Gap: ethical issues of private treatment in the public health system.
Fenton E
N Z Med J; 2011 May; 124(1334):89-96. PubMed ID: 21946640
[TBL] [Abstract][Full Text] [Related]
14. Cancer therapy costs influence treatment: a national survey of oncologists.
Neumann PJ; Palmer JA; Nadler E; Fang C; Ubel P
Health Aff (Millwood); 2010; 29(1):196-202. PubMed ID: 20048377
[TBL] [Abstract][Full Text] [Related]
15. Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey.
Schrag D; Hanger M
J Clin Oncol; 2007 Jan; 25(2):233-7. PubMed ID: 17210946
[TBL] [Abstract][Full Text] [Related]
16. Physicians' Perspectives on Ethical Issues Regarding Expensive Anti-Cancer Treatments: A Qualitative Study.
Bomhof CHC; Schermer M; Sleijfer S; Bunnik EM
AJOB Empir Bioeth; 2022; 13(4):275-286. PubMed ID: 36017997
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of attitude and recommendation of oncologists toward exercise in South Korea: a cross sectional survey study.
Park JH; Oh M; Yoon YJ; Lee CW; Jones LW; Kim SI; Kim NK; Jeon JY
BMC Cancer; 2015 Apr; 15():249. PubMed ID: 25886264
[TBL] [Abstract][Full Text] [Related]
18. The effect of priority setting decisions for new cancer drugs on medical oncologists' practice in Ontario: a qualitative study.
Berry SR; Hubay S; Soibelman H; Martin DK
BMC Health Serv Res; 2007 Nov; 7():193. PubMed ID: 18042302
[TBL] [Abstract][Full Text] [Related]
19. Views of advanced cancer patients, families, and oncologists on initiating and engaging in advance care planning: a qualitative study.
Toguri JT; Grant-Nunn L; Urquhart R
BMC Palliat Care; 2020 Oct; 19(1):150. PubMed ID: 33004023
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
